Focusing on malignant melanoma, the triple blockade of PD1, TIM3 and BTLA leads consecutively to an increased expansion, proliferation and cytokine production of tumor-associated antigen- specific CD8+ T-cells [121]. Here, CD8A is linked to melanoma.